January 2013
Detailed Clinical Trial Description
A study to evaluate the safety and effect of experimental drugs ABT-450, ABT-267, ABT-333, ritonavir, and Ribavirin
in people with HCV. The study will test the
safety and effects of combinations of these drugs in treatments up to 24 weeks.